Exchange-coupled magnetic nanoparticles for efficient heat induction

The conversion of electromagnetic energy into heat by nanoparticles has the potential to be a powerful, non-invasive technique for biotechnology applications such as drug release 1 , 2 , 3 , disease treatment 4 , 5 , 6 and remote control of single cell functions 7 , 8 , 9 , but poor conversion effic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature nanotechnology 2011-06, Vol.6 (7), p.418-422
Hauptverfasser: Lee, Jae-Hyun, Jang, Jung-tak, Choi, Jin-sil, Moon, Seung Ho, Noh, Seung-hyun, Kim, Ji-wook, Kim, Jin-Gyu, Kim, Il-Sun, Park, Kook In, Cheon, Jinwoo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The conversion of electromagnetic energy into heat by nanoparticles has the potential to be a powerful, non-invasive technique for biotechnology applications such as drug release 1 , 2 , 3 , disease treatment 4 , 5 , 6 and remote control of single cell functions 7 , 8 , 9 , but poor conversion efficiencies have hindered practical applications so far 10 , 11 . In this Letter, we demonstrate a significant increase in the efficiency of magnetic thermal induction by nanoparticles. We take advantage of the exchange coupling between a magnetically hard core and magnetically soft shell to tune the magnetic properties of the nanoparticle and maximize the specific loss power, which is a gauge of the conversion efficiency. The optimized core–shell magnetic nanoparticles have specific loss power values that are an order of magnitude larger than conventional iron-oxide nanoparticles. We also perform an antitumour study in mice, and find that the therapeutic efficacy of these nanoparticles is superior to that of a common anticancer drug. The properties of core–shell nanoparticles can be tuned so that they efficiently convert radiation into heat, leading to therapeutic results that are competitive with commercial drug treatments.
ISSN:1748-3387
1748-3395
DOI:10.1038/nnano.2011.95